Monday, August 31, 2026

Gevo Stock Drops By 27% In The Last 21 Sessions

Gevo Stock Drops By 27% In The Last 21 Sessions

(VIANEWS) - Shares of Gevo (NASDAQ: GEVO) dropped by a staggering 27.27% in 21 sessions from $1.54 at 2023-03-27, to $1.12 at 14:38 EST on Wednesday, following the last session's downward trend. NASDAQ is jumping 0.69% to $11,880.90, after two consecutive sessions in a row of losses.

Gevo's last close was $1.12, 76.72% below its 52-week high of $4.81.

About Gevo

Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.42.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -17%.

Sales Growth

Gevo's sales growth is 1193.1% for the ongoing quarter and 2147.2% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 909.3%, now sitting on 1.18M for the twelve trailing months.

Volume

Today's last reported volume for Gevo is 3023483 which is 56.76% below its average volume of 6452510.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Gevo's stock is considered to be overbought (>=80).

More news about Gevo (GEVO).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com